HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Icard, Ph. Articles by Levasseur, Ph. Search for Related Content PubMed PubMed Citation Articles by Icard, Ph. Articles by Levasseur, Ph.

Eur J Cardiothorac Surg 1999;15:426-432
© 1999 Elsevier Science NL

Survival and prognostic factors in patients undergoing parenchymal saving bronchoplastic operation for primary lung cancer: a series of 110 consecutive cases

Department of Thoracic Surgery, Marie Lannelongue Hospital, Le Plessis Robinson, France

Received 12 October 1998; received in revised form 13 January 1999; accepted 27 January 1999.

Corresponding author. Service de Chirurgie Thoracique et Vasculaire, Centre Chirurgical Marie Lannelongue, 133 avenue de la résistance, Le Plessis Robinson, 92350, France. Tel.: +33-1-4094-2800; fax: +33-1-4094-5582.

Objective: The purpose of this study was to report our experience concerning bronchial sleeve lobectomy for treating bronchogenic cancer. Method: From 1980 to 1994, 110 patients underwent bronchial sleeve lobectomy for bronchogenic cancer. In 45 patients, preoperative investigations contraindicated pneumonectomy, whereas in 65 other patients, sleeve resection was performed without functional necessity. The most common procedures were sleeve lobectomy of the right upper lobe (64%), and of the left upper lobe (21%). Sixteen patients (15%) underwent additional arterial vascular resection. Seven patients had microscopic invasion of the bronchial margin without the possibility of further resection in six with regard to their limited respiratory function. Tumors were staged as follow: 32 stage IB (all T2 N0), 57 stage IIB (57T2 N1), and 17 stage IIIA (eight, T3N1; nine, T2N2), whereas four patients had an in situ cancer (four stage 0). Results: Operative mortality was 2.75%. The 5- and 10-year actuarial survival rates were, respectively, 39 and 22% for the entire group. The 5-year actuarial survival rates were, 60% in stage IB, 30% in stage IIB, and 27% in stage IIIA. Four factors significantly influenced survival (P<0.05): nodal stage, arterial resection, invasion of the bronchial stump and poor functional respiratory status contraindicating pneumonectomy. Conclusions: In our experience, sleeve resection for stage I provides comparable survival to that of standard resection at equal stage. However, in patients with pathologically N1 disease, who can tolerate a pneumonectomy, a randomized study is mandatory to confirm that sleeve lobectomy can be performed without the risk of decreasing long-term survival. In our study, patients who required an associated vascular resection demonstrated a poor survival.

Key Words: Pulmonary neoplasms • Surgery • Bronchial sleeve resection

This article has been cited by other articles:

				F. Venuta, A. M. Ciccone, M. Anile, M. Ibrahim, T. De Giacomo, G. F. Coloni, and E. A. Rendina Reconstruction of the pulmonary artery for lung cancer: Long-term results J. Thorac. Cardiovasc. Surg., November 1, 2009; 138(5): 1185 - 1191. [Abstract] [Full Text] [PDF]

				M. Alifano, G. Cusumano, S. Strano, P. Magdeleinat, A. Bobbio, F. Giraud, B. Lebeau, and J.-F. Regnard Lobectomy with pulmonary artery resection: Morbidity, mortality, and long-term survival. J. Thorac. Cardiovasc. Surg., June 1, 2009; 137(6): 1400 - 1405. [Abstract] [Full Text] [PDF]

				F. Rea, G. Marulli, M. Schiavon, A. Zuin, A.-M. Hamad, G. Rizzardi, E. Perissinotto, and F. Sartori A quarter of a century experience with sleeve lobectomy for non-small cell lung cancer Eur. J. Cardiothorac. Surg., September 1, 2008; 34(3): 488 - 492. [Abstract] [Full Text] [PDF]

				P. Bagan, P. Berna, J. C. Das Neves Pereira, F. Le Pimpec Barthes, C. Foucault, A. Dujon, and M. Riquet Sleeve Lobectomy Versus Pneumonectomy: Tumor Characteristics and Comparative Analysis of Feasibility and Results Ann. Thorac. Surg., December 1, 2005; 80(6): 2046 - 2050. [Abstract] [Full Text] [PDF]

				F. Chunwei, W. Weiji, Z. Xinguan, N. Qingzen, J. Xiangmin, and Z. Qingzhen Evaluations of bronchoplasty and pulmonary artery reconstruction for bronchogenic carcinoma Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 209 - 213. [Abstract] [Full Text] [PDF]

				A. Terzi, A. Lonardoni, G. Falezza, G. Furlan, P. Scanagatta, F. Pasini, and F. Calabro Sleeve lobectomy for non-small cell lung cancer and carcinoids: results in 160 cases Eur. J. Cardiothorac. Surg., May 1, 2002; 21(5): 888 - 893. [Abstract] [Full Text] [PDF]

				A.E. Martin-Ucar, N. Chaudhuri, J.G. Edwards, and D.A. Waller Can pneumonectomy for non-small cell lung cancer be avoided? An audit of parenchymal sparing lung surgery Eur. J. Cardiothorac. Surg., April 1, 2002; 21(4): 601 - 605. [Abstract] [Full Text] [PDF]

				P. H. Hollaus, D. Janakiev, and N. S. Pridun Telescope anastomosis in bronchial sleeve resections with high-caliber mismatch Ann. Thorac. Surg., August 1, 2001; 72(2): 357 - 361. [Abstract] [Full Text] [PDF]

				H. F. Lausberg, T. P. Graeter, O. Wendler, S. Demertzis, D. Ukena, and H.-J. Schafers Bronchial and bronchovascular sleeve resection for treatment of central lung tumors Ann. Thorac. Surg., August 1, 2000; 70(2): 367 - 371. [Abstract] [Full Text] [PDF]

				P. E. Van Schil, J. Vankeirsbilck, A. B. de la Riviere, and J. M. van den Bosch Long-term survival after bronchial sleeve resection in relation to nodal involvement Eur. J. Cardiothorac. Surg., February 1, 2000; 17(2): 196 - 197. [Full Text] [PDF]